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A B S T R A C T
In light of the increasing threats of chronic noncommunicable diseases in developing countries, the growing
recognition of the early life origins of chronic disease, and innovative breakthroughs in biomedical research
and technology, it is imperative that we harness cutting-edge data to improve health promotion and
maintenance. It is well recognized that chronic diseases are complex traits affected by a wide range of
environmental and genetic factors; however, the role of epigenetic factors, particularly with regard to early
life origins, remains largely unexplored. Given the unique properties of the epigenome—functionality during
critical time windows, such as the intrauterine period, heritability, and reversibility—enhancing our under-
standing of epigenetic mechanisms may offer new opportunities for the development of novel early predic-
tion and prevention paradigms. This may present an unparalleled opportunity to offer maternal and child
health professionals important tools with the translational value to predict, detect, and prevent disease at an
early age, long before its clinical occurrence, and as such, break lifelong and transgenerational cycles of
disease. In doing so, modern technology can be leveraged to make great contributions to population health,
quality of life, and reducing the burdensome economic costs of noncommunicable diseases in developing
countries. 2013 Society for Adolescent Health and Medicine.
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Open access under CC BY-NC-ND license.Human health is interconnected throughout the life span
rom conception to fetal life to early childhood and adolescence
nd on into adulthood and the senior years. Each stage presents
ts own unique health needs and problems, yet each of them is
nterconnected. There is compelling evidence that early life may
ave a profound impact on health and disease in later life [1–3].
or example, there are four critical periods for the development
f obesity: prenatal, early childhood, adolescence, and preg-
ancy [4]. As related to the prenatal period, with few nutrients,
etal systems develop to thrive in a world of scarcity, which
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Open access under CC BY-Nanifests in reduced fetal growth. However, after birth, this
thrifty phenotype” becomes a liability when the postnatal envi-
onment provides many more calories and nutrients than the
etal adaptations have predicted. These “double hits” can lead to
etabolically disadvantageous phenotypes and increased sus-
eptibility to disease in later life.
Despite the extensive efforts of biomedical research taking
lace mostly in developed countries, we have made little
rogress toward preventing chronic noncommunicable dis-
ases. In light of the increasing threats of chronic noncommu-
icable diseases in developing countries, the growing recog-
ition of early life origins of chronic diseases, and the
emarkable breakthroughs in biomedical research and tech-
ology, a new approach to health promotion and maintenance
n developing countries needs to be explored and developed.
he new focus must be on shifting the timing of our interven-
ions from clinical disease to preclinical precursors that allow
C-ND license.
G. Wang et al. / Journal of Adolescent Health 52 (2013) S14–S21 S15us to prevent and/or intervene prior to disease onset. By doing
so, we will be able to improve child and adolescent health, as
well as population health and quality of life, and also work to
reduce health care costs.
It is well recognized that chronic diseases are complex traits
that are affected by a wide range of environmental and genetic
factors. The epigenome is an important link between genetic
inheritance and environmental factors, playing a particularly
crucial role in the early life origins of chronic diseases. The ex-
citement and promise of epigenetic research stem from its
unique properties, including heritability, functionality during
critical developmental windows, and reversibility. Regarding
criticalwindows, evidence fromanimalmodels andhuman stud-
ies implicates the intrauterine period as a highly sensitive time
for the establishment of epigenetic variability, which in turn
inﬂuences risk for a range of disorders that can develop later in
life [5–7]. Moreover, developmental plasticity from preconcep-
tion to early childhood involves epigenetic responses to environ-
mental inﬂuences, which exert long-term health effects. These
epigenetic responses shape development, cell- and tissue-
speciﬁc gene expression, and sexual dimorphism. A more sub-
stantive review of epigenetics can be found in the Epigenetics
and Early Life Origins of Disease section.
Using the examples of obesity and mental illness, both of
which are highly prevalent in developing and developed coun-
tries alike, this review underscores the importance of under-
standing early life origins of chronic noncommunicable diseases
with a particular focus on epigenetics as a possible biological
mechanism. Given the distinctive properties of the epigenome
and its relation to gene expression and environmental factors,
understanding epigeneticmechanisms could offer new opportu-
nities for the development of novel early prediction and preven-
tion paradigms. We are optimistic that this new paradigm will
not only contribute to more cost-effective health care over the
long term, but will also help to break intransigent lifelong and
transgenerational cycles of chronic noncommunicable diseases
prevalent in developing countries.
Evolving Paradigms of Early Life Origins of Disease
Early in 1934, the Early Life Origins of Adult Disease hypoth-
esis was proposed by Kermack et al, who suggested that de-
creased death rates due to all causes in the United Kingdom and
Sweden between 1751 and 1930 were the result of improved
childhood living conditions [8]. In 1962, Neel extended on this
hypothesis by proposing that exposure to periods of famine
resulted in selection pressures in favor of a “thrifty genotype,”
which led to maladaptive levels of overly efﬁcient fat storage
during periods of abundance [9]. In 1977, Forsdahl reported that
nutritional deﬁcit during childhood may exacerbate later-life
vulnerability to arteriosclerotic heart disease when exposed to a
more afﬂuent and nutritionally abundant adult lifestyle [10].
Subsequently, Baker et al found that the restraint of growth
during fetal life and infancy may increase the risk for cardiovas-
cular disease and reduced glucose tolerance in adult life. Based
on this ﬁnding, he proposed the “thrifty phenotype hypothesis,”
which espouses the idea that poor nutrition in fetal and early
infancy is detrimental to beta cell function and predisposes the
individual to developing type 2 diabetes later in life [11–13].
Further development in the ﬁeld extended this paradigm into
what became known as the Fetal Origin of Adult Disease hy-
pothesis. The Fetal Origin of Adult Disease hypothesis con-tends that environmental inﬂuences during fetal life can inﬂu-
ence adult health through various mechanisms including
developmental plasticity, fetal programming, and epigenetics
[14–16]. This idea was further expanded into the develop-
mental origins of health and disease paradigm, which has
received tremendous attention over the past 25 years and
reﬂects ideas that have been debated since the ﬁeld of genetics
gained widespread acceptance [17,18].
Nutrition in early life and its effect on obesity
Prenatal nutrition is arguably one of the most important con-
tributing factors to obesity. Abundant evidence supports the
relationship between the prenatal nutritional environment, pat-
terns of postnatal growth, and adult adiposity. For example, a
high prevalence of obesity was found at both high and low birth
weights, which were associated with obesity in childhood and
adult life [19,20]. Additionally, roughly half of the children who
were large for gestational age at birth were overweight at age 8
years [21]. Alternatively, although infants who were small for
gestational age tended to have a lower bodymass index (BMI) in
adulthood, they were prone to a higher level of central obesity
than individualswhowere large at birth [22–24]. A ﬁnal example
is provided by the well-known Dutch Winter Famine (“Honger-
winter”) study, which examined long-term health outcomes of
children born to mothers starved during pregnancy because of a
Nazi blockage of the food supply lines during the Second World
War. As adults, these children experienced signiﬁcantly higher
rates of type 2 diabetes and cardiovascular disease relative to
their peers whose mothers had adequate nutritional intake dur-
ing pregnancy [25].
Exposure to environmental toxins in early life and its effect on
obesity
Research has also linked early life exposure to environmental
toxins with obesity and chronic illness later in life. Numerous
studies have found thatmaternal cigarette smoking during preg-
nancy is associatedwith reducedbirthweight or increased risk of
lower birth weight [26,27]. Additionally, associations have been
found between maternal smoking in pregnancy and offspring
obesity [28]. Previous work from our research team found that
smokingmotherswith speciﬁc genotypeswere at a higher risk of
delivering low-birth-weight infants [29]. These ﬁndings suggest
that a speciﬁc gene–environment (GxE) interaction between
maternalmetabolic genes and cigarette smokingmay contribute
to offspring obesity later in life. Further evidence comes from a
study on endocrine-disrupting chemicals, which may alter the
normal functioning of hormones and other signaling molecules,
including estrogens, androgens, thyroid, hypothalamic, andpitu-
itary hormones [30,31]. Prenatal exposure to these endocrine-
disrupting chemicals may play a role in shaping BMI later in life.
For example, a correlationwas found between prenatal exposure
to dichlorodiphenyl dichloroethene, a known endocrine dis-
rupter, and increased BMI in young children [32]. Similar effects
were also found in boys at puberty [33].
Epigenetics and early life origins of disease
Epigenetic programmingmaybe amechanismunderlying the
early life origins of chronic disease via regulation of gene expres-
sion through DNA methylation, histone modiﬁcations, chromatin
s
b
t
c
l
a
g
k
T
a
n
v
t
w
g
a
g
h
p
g
m
s
m
l
w
I
t
p
v
e
t
v
o
a
t
i
G. Wang et al. / Journal of Adolescent Health 52 (2013) S14–S21S16remodeling, and/or regulatory feedback by way of microRNAs.
Epigenetic mechanisms are important because of the effect they
can have on the roughly 25,000 genes that comprise human
DNA. Stated simply, genes or alleles (speciﬁc forms of genes)
can be thought of as “recipes” for unique protein products that
interact to create the biochemical blueprint underlying devel-
opment. Epigenetic effects can silence genes entirely, or cause
them to overproduce/overexpress (hypomethylate) or under-
produce/underexpress (hypermethylate) the gene’s protein
product, inﬂuencing the downstream biochemical milieu that
underpins all dimensions of complex behavior, including hu-
man health. Growing evidence supports the likelihood that
the overwhelming majority of chronic human diseases are
driven by acquired changes in genomic expression over the
life course.
Research shows that epigenetic patterns are dynamic in re-
sponse to both internal and external environmental stimuli
throughout the life cycle [34,35]. For example, demographic fac-
tors (e.g., age and gender), environmental exposures (cigarette
smoke, diet, lifestyle, maternal nurturing, air pollution, micro-
bial infections), and genetic variations can all inﬂuence epige-
netic patterns [36–40]. Converging these lines of evidence
upports the possibility that epigenetics may be a causal link
etween the genotype and environment, and hence, between
he phenotype and disease. Of note, although epigenetic expres-
sion patterns can persist over the long term, they are nonetheless
potentially reversible, presentingas-yetundeﬁnedopportunities to
optimize gene expression andhealth outcomes over the life course.
As described earlier, epigenetic changes may reﬂect the mo-
lecular consequences of genetic variants, environmental expo-
sures, and GxE interactions. One example is provided by the
ﬁnding that a low-protein diet during pregnancy was associated
with decreased DNA methylation of the angiotensin receptor
gene in offspring, explaining the increase in blood pressure
among the study animals [41]. Another study in rats found that
epigenetic modiﬁcations were associated with differential pat-
terns of insulin-like growth factor 1 gene expression in intrauter-
ine growth-restricted offspring, and suggested that these differ-
ences may have been associated with either rapid or delayed
postnatal catch-up growth [42]. More evidence comes from an
animal study that found epigenetic alterations induced by in
utero and postnatal exposure to chemical compounds, such as
bisphenol A [43–45], polybrominated diphenyl ethers [46], and
polychlorinated biphenyls [47]. Interestingly, the hypomethylat-
ing effects of BPA can bemitigated bymaternal folic acid supple-
mentation, providing a preventative environmental solution to
an adverse epigenetic effect [43]. In summary, animal research in
epigenetics has revealed novel mechanisms to elucidate detri-
mental health effects arising from early life adversities, as sug-
gested by the metabolic imprinting theory [48]. The basic hy-
pothesis is that intrauterine exposure can permanently change
fetal metabolic patterns and modify long-term risk for disease.
This “fetal programming” appears to be largely independent of
the genomic DNA sequence, and is likely mediated by epigenetic
mechanisms.
Research in humans found that impaired glucosemetabolism
during pregnancy was associated with increased leptin gene
methylation in offspring [49], exacerbating the long-term risk of
developing obesity and type 2 diabetes in children born to
women with gestational diabetes. Another human study pro-
vided evidence for differential methylation levels in response to
dietary intervention. After an 8-week hypocaloric diet, methyl- Ration patterns in 170 locations on particular geneswere substan-
tially changed: 70 were demethylated by20% (overexpressed)
and 100 were methylated by 20% (underexpressed), which
resulted in either over- or underproduction of the gene’s protein
product [50]. Moreover, there is evidence for epigenetic activity
in transgenerational inheritance in humans [51]. Support comes
from studies of human imprinting disorders, where alleles of
particular genes are silenced (incorrectly expressed) because of a
speciﬁc epigenetic ﬂaw in theDNAof oneparent [52,53]. In short,
epigenetic mechanisms may operate in conjunction with envi-
ronmental inﬂuences, but there is also evidence that aspects of
methylation maintenance and methylation changes over time
are under genetic control [6].
Early Life Origins of Obesity and Epigenetic Patterns
There is increasing epidemiologic evidence linking early life
factors to later adiposity [1,25,54]. Although our present under-
standing of the underlying mechanisms is limited, some evi-
dence suggests that epigenetic processes represent an important
link between the early environment and obesity later in life
[55,56]. For example, diet/nutrition represents amajor risk factor
for the development of obesity. A few studies have indicated that
diet-induced obesity is under epigenetic regulation [57–62]. For
example, methylation levels in the promoter region of the reti-
noid X receptor- gene at birth were associated with maternal
arbohydrate intake in early pregnancy, as well as adiposity in
ater childhood [60]. Periconceptional exposure to famine was
ssociated with a decrease in DNA methylation of insulin-like
rowth factor 2 [61] and an increase in methylation of interleu-
in 10 and leptin, two obesity-related candidate genes [63].
able 1 summarizes several examples of nutritionally induced
lterations of methylation patterns.
A growing body of evidence points to epigenetic mecha-
isms as mediators of obesity risk, as has recently been re-
iewed [64]. Limited studies in humans have demonstrated
hat not only is global DNA methylation positively associated
ith BMI [65], but also that DNAmethylation levels in speciﬁc
enes (including UBASH3A and TRIM3) vary between obese
nd lean individuals [66]. In addition, the role of imprinted
enes in bodyweight [67] and the development of obesity [68]
ave previously been summarized. Current evidence also sup-
orts the role of epigenetic effects in the regulation of key
enes involved in adipogenesis, glucose homeostasis, inﬂam-
ation, and/or insulin signaling [58,69–77]. These genes are
ummarized in Table 2.
Further evidence connecting obesity with epigenetic
echanisms comes from ﬁndings linking histone (an intracel-
ular protein that packages and organizes DNA) modiﬁcation
ith microRNA activity in the development of obesity [78,79].
n the early stages of adipogenesis, hyperacetylation of his-
one H3 and trimethylation of histone H3 Lys4 (H3K4) are
ositively associated with apM1 gene transcription. Con-
ersely, inhibition of H3K4 methylation decreases apM1 gene
xpression and modiﬁes adipogenesis, indicating an impor-
ant role of epigenetic factors [75]. Another example is pro-
ided by an animal study, which found that the loss of function
n an area of histone H3 may regulate peroxisome proliferator–
ctivated receptor  and its target genes via modiﬁed levels of
he gene’s protein product, resulting in obesity and hyperlip-
demia [78]. Finally, a human study reported that 70 micro-
NAs were highly and signiﬁcantly up- or downregulated
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product) in mature adipocytes as compared with preadi-
pocytes; 17 microRNAs were correlated with BMI, fasting glu-
cose, and/or triglycerides, and 11 microRNAs were signiﬁ-
cantly deregulated in subcutaneous fat from obese subjects
with and without type 2 diabetes [80]. In conclusion, a grow-
ing body of research supports the role of epigenetics as an
important mechanism underlying the development of obesity.
Further studies elucidating the association between DNA
methylation status, increased fat mass, and obesity are war-
ranted to validate existing research.
Epigenetics and Early Life Origins of Mental Health Problems
Although the primary focus of this review relates to the
epigenetics of obesity and its related long-term health issues,
evidence for differential gene expression patterns and related
health outcomes also exists in the arena of psychiatric illness.
Several studies have pointed to the association between pre-
natal and early life epigenetic mechanisms and long-term
psychiatric outcomes [81–84]. Research in rodents found that
variations in maternal care alter the expression of genes reg-
ulating behavioral and endocrine responses to stress, as well
as hippocampal synaptic development [81]. Data from a hu-
man population found that a gene that codes for a glucocorti-
coid receptor co-chaperone protein was implicated in child
abuse–associated risk of amajor depressive disorder and post-
traumatic stress syndrome [82,83]. Further evidence for the
link between psychosocial stress and epigenetics stems from
the ﬁnding that social isolation can impair the transcription of
glucocorticoid response genes, and moreover increase proin-
ﬂammatory activity in humans [69]. Epigenetics also have been
Table 1
Examples of nutritionally induced alterations of methylation patterns
Diet Modiﬁed gene
Gene name
High-fat diet Melanocortin 4
Leptin
Neonatal overfeeding Pro-opiomelano
Lower maternal carbohydrate intake in early pregnancy Retinoid X rece
Periconceptional exposure to famine Insulin-like gro
Interleukin 10
Leptin
A low-protein diet during pregnancy Imprinted mate
Insulin-like gro
1 increased level of methylation;2 decreased level of methylation.
Table 2
Examples of genes involved in the regulation of adipogenesis, glucose homeosta
Gene name Abbreviation
Peroxisome proliferator–activated receptor  PPARG
The adipose most abundant transcript 1 apM1
Fatty acid-binding protein 4 FABP4
Tumor necrosis factor TNF
Leptin LEP
Lipoprotein lipase LPL
Insulin INS
Glucose transporter GLUT4
Melanin-concentrating hormone receptor 1 MCHR1
Fat mass and obesity associated FTOa Chr  chromosome.shown toplay a role in the link between stress and addiction [85],
as well as the development of habit-forming behaviors [86],
particularly when substance abuse begins early in life [85,87].
One study found that ethanol administration in rats during a
developmental stage equivalent to human adolescence led to
increased voluntary alcohol intake as adults [88], an outcome
associated with epigenetic changes in the frontal cortex, stria-
tum, and nucleus accumbens, as well as decreased dopamine
expression in dopamine receptors 1 and 2. This suggests that
epigenetic changes in adolescents contribute to long-lasting
neurobiological consequences associated with early life ethanol
administration by causing brain region–speciﬁc changes in sig-
naling and neuroplasticity [88].
Research ﬁndings for drug abuse yield a similar pattern.
merging data suggest that epigenetic regulation may be the
olecular basis of drug-induced changes in gene expression in
rain reward regions, contributing to the lasting neural and
ehavioral plasticity that underlies addiction [89]. Recre-
tional drugs activate neural reward centers, such as the me-
olimbic dopamine system, exerting rapid effects on behavior.
or example, transient increases in members of the transcrip-
ion factor Fos family are observed on acute exposure to drugs
f abuse [90]. The expression of transcription factor FosB in
eurons has led to the theory that it plays a signiﬁcant role
n the onset of addiction [91–93]. Manipulation of these genes
n rodent models has been associated with the regulation of
rug relapse behavior [92,94–96]. In short, epigenetic changes
ediated by the interaction of inherited predispositions, environ-
ental stimuli, andexposure todrugscan trigger long-lastingalter-
tions in gene expression that inﬂuence susceptibility to addictive
ehaviors [97].
Alteration in
methylation
Reference
Abbreviation
tor Mc4r 1 57
LEP 1 58
POMC 1 59
RXRA 1 60
ctor 2 IGF-2 2 61
IL-10 1 63
LEP 1 63
expressed transcript H19 1 62
ctor 2 IGF-2 1 62
ﬂammation, and/or insulin signaling
Chra Pathway Reference
3 PPAR signaling pathway 70,74
3 Adipocytokine signaling pathway 75
4 PPAR signaling pathway 70
6 Apoptosis and autophagy 76
7 Adipocytokine signaling pathway 58
8 PPAR signaling pathway 70
11 Insulin signaling pathway 71,69
17 Insulin signaling pathway 73
22 G protein-coupled receptor signaling 72
16 Regulation of lipid storage 77recep
cortin
ptor 
wth fa
rnally
wth fasis, in
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Chronic Disease
Epigenetics as a biological mechanism of the early life origin of
disease
To date, few longitudinal studies have been designed to ex-
amine the role of epigenetic alterations in relation to early life
adversities and the development of chronic noncommunicable
diseases. Given the rising prevalence and burgeoning economic
costs of noncommunicable diseases such as obesity and psychi-
atric illness worldwide, it is critical to harness cutting-edge re-
search to examine the many important questions that remain
unanswered. For example, to what degree do early life adversi-
ties (e.g., nutrition, stress, abuse, smoking, endocrine disrupters,
and sleep) affect the epigenome? What are the critical time
windows for imprinting, metabolic reprogramming, and epig-
enomic reversibility? Which early life risk factors are most
closely linked to epigenetic alterations, and are biologically em-
bedded to cause lifelong or even transgenerational conse-
quences? How can we apply new scientiﬁc evidence and knowl-
edge, and in particular, information related to critical time
windows of developmental reprogramming, and reversibility of
the epigenome to transform our approach to research and pre-
vention of chronic diseases? Longitudinal birth cohort studies
harnessing the expertise of interdisciplinary researchers are crit-
ically needed to identify links among community and family
inﬂuences, early life adversities, genetics, epigenomic altera-
tions, and the development of chronic diseases in children and
adolescents. Such multilevel research has the potential to pro-
vide important insight into the biological mechanisms by which
environmental exposures affect growth, development, and dis-
eases over a life course and across generations.
Epigenetics and translational medicine
Much of the excitement surrounding epigenetics today re-
lates to the reversible nature of epigenetic alterations and the
promise of therapies that may restore the “normal epigenome”
by activating or silencing disease-related genes. For example,
two epigenetic drugs that reactivate tumor suppressor genes
have recently received approval of the Food and Drug Adminis-
tration [98,99], highlighting the tremendous promise of transla-
tional medicine throughmapping and understanding epigenetic
mechanisms. Translational epigenetic research in children’s
health is a reiterative process that ranges from research in the
basic sciences to preclinical research and pediatric clinical re-
search. Applying the latest scientiﬁc discoveries and subsequent
clinical studies in pediatric and later years, we have the potential
tomaximize the impact of newly developed and tested interven-
tions across the life span, preventing childhood and adult onset
of disease by identifying risk at a very young age. This may allow
clinicians to deliver targeted counteractive measures before
symptoms of the disease become manifest. For example, identi-
fying the epigenetic consequences of fetal programming creates
potential applications in clinical practice: the development of
epigenetic biomarkers for early diagnosis of disease, the ability to
identify susceptible individuals at risk for adult diseases, and the
development of novel preventive and curativemeasures that are
based on diet, exercise, and/or novel epigenetic drugs [100].The
completion of the human genome and epigenome projects will
enhance our understanding of the genetics and epigenetics un-derlying growth, development, health, and disease. At present,
genome-wide association study (GWAS) is the most powerful
tool we have for dissecting the genetic basis of complex human
diseases. GWAS to date have led to the identiﬁcation of impor-
tant susceptibility genes; however, we still lack a complete un-
derstanding of the global architecture of genetic and epigenetic
regulatory networks that lead to the development of complex
human diseases. It is anticipated that epigenomic studies in
conjunction with GWAS will help us gain important new insight
into the interrelationships between early life exposures, epige-
netic alterations, and the development of chronic diseases: data
that can ultimately be harnessed in clinical settings for preven-
tative purposes [101,102].
Although there are signiﬁcant costs associated with conduct-
ing genomic and epigenetic research, sequencing prices are
dropping precipitously. The commensurate decreases in cost and
increases in processing speed will greatly bolster the time and
cost efﬁciencies involved in gathering this critically needed data.
Falling costs and increasing efﬁciencies notwithstanding, it is
important to consider that effective translation of epigenetic
data into clinical settings will require a sizeable investment,
although the timeline for the return on this investment is as yet
unclear. However, the tremendous potential for epigenetic re-
search to provide valuable translational data, which will allow
the medical community to understand, treat, and ultimately
prevent chronic disease, makes the long-term investment not
only worthwhile but essential. For economic reasons, invest-
ment and research related to these technologies will be led
primarily by developed countries. However, the ultimate aim is
to reach a milestone where economic beneﬁts outweigh the
costs, whichwill spur translation into clinical settings, bolstering
health outcomes and quality of life in developed and underde-
veloped countries alike.
Interdisciplinary and international collaborations to advance 21st
century medicine and public health
The rapid advancement in biomedical research and biotech-
nologies has offered unprecedented opportunities to improve
human health in developing countries. Although it remains a
tremendous challenge to translate these advancements into
practice, it is critical that we strive for lofty short- and long-term
goals. Although we have learned to treat disease, using increas-
ingly sophisticated technologies and agents, we lack a pragmatic
understanding of how to prevent it. “P4 Medicine” with each P
representing predictive, preventive, personalized, and participa-
tory, is the optimal, if ambitious, direction for 21st century med-
icine and public health.
Our ability to predict future risk will be greatly improved
by combining information related to genetic susceptibility,
environmental exposures, GxE interactions, and epigenetic
and biochemical markers. Accurate early prediction is a key to
preemptive prevention, a strategy that emphasizes using bio-
markers at the earliest possible point to identify susceptible
populations and initiate preventative strategies before the
onset of disease, that is, at the preclinical stage. By shifting the
timing of our focus from clinical disease to preclinical precur-
sors, we will be able to move toward the ultimate goal of 21st
century medicine—preventing and intervening before the on-
set of clinical disease. By doing so, we will be able to improve
child and adolescent health, population health and quality of
life, and thereby reduce health care costs.
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G. Wang et al. / Journal of Adolescent Health 52 (2013) S14–S21 S19This vision is not without challenges; however, despite the
any scientiﬁc, social, regulatory, political, and economic difﬁ-
ulties, broad-reaching agencies such as the Food and Drug Ad-
inistration and National Institutes of Health have placed high
riority on the use of biological data to optimize health outcomes
nd the effectiveness of public health policy [103]. Although this
rticle uses the noncommunicable diseases of obesity and psy-
hiatric illness as examples, wemust consider individual biolog-
cal characteristics and how they interact with accrued environ-
ental experiences over critical timewindows tomove the ﬁeld
orward. These types of complex studies will also require novel
tudy designs, including large longitudinal birth cohorts, multi-
evel andmulti-faceted data collection, and innovative analytical
ethods, to be effective. Understanding the etiology of chronic
iseases will require massive data sets generated from -omics
esearch and close collaborations among investigators from
any disciplines, across the country and around the globe.
ummary
In light of the increasing threats of chronic noncommunicable
iseases in developing countries, the growing recognition of
arly life origins of disease, and the remarkable breakthroughs in
iomedical research and technology, a new approach to health
romotion andmaintenance in developing countries needs to be
xplored and developed. The new focus must be on shifting the
iming of our interventions from clinical disease to preclinical
recursors, to allow us to prevent and/or intervene before the
nset of clinical disease. This approach places great emphasis on
omen’s and children’s health, and underscores the importance
f early risk assessment, identiﬁcation, and prevention.
It is well recognized that chronic diseases are complex traits
hat are affected by a wide range of environmental and genetic
actors. In contrast, the role of epigenetic factors, particularly
ith regard to early life origins of chronic disease, remains
argely unexplored. Evidence from animal models and human
tudies implicates the intrauterine period as a most sensitive
ime for the establishment of epigenetic variability, which in
urn inﬂuences development, cell- and tissue-speciﬁc gene ex-
ression, sexual dimorphism, and risk for a range of disorders
hat can develop later in life. Given the unique properties of the
pigenome—critical timewindows, heritability, and reversibility—
nd its relation to gene expression and environmental factors, a
eeperunderstandingofepigeneticmechanismscouldoffer impor-
antnewopportunities for thedevelopmentof anovel earlypredic-
ion and prevention paradigm. We expect that this new paradigm
olds the promise to develop cost-effective prevention and inter-
ention strategies, but may also help break vicious lifelong and
ransgenerational cycles of chronic noncommunicable disease. Pe-
iatricians and maternal and child health professionals have an
nprecedented opportunity to play an important role in predicting,
etecting, and preventing disease at an early age, long before its
linical occurrence. In doing so, great strides can bemade inmater-
al and child health as well as population health, to ultimately
nhance quality of life and reduce health care costs in developing
ountries.
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